SCHEMBL7474403

SCHEMBL7474403

O=c1ccc2cc3c(cc2[nH]1)NC=CO3

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.43
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
F11 P03951 1/20 0.40
CA1 P00915 1/20 0.37
CA3 P07451 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA13 Q8N1Q1 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
AR P10275 1/20 0.33
POLB P06746 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29433749 0.80 MAPK1 (0.50) MAPK1CA12CA9F11CA1
SCHEMBL7107394 0.71 POLB (0.36) MAPK1POLB
SCHEMBL13849653 0.68 KDM4E (0.50) MAPK1CA12CA9F11CA1
SCHEMBL13849661 0.66 MAPK1 (0.46) MAPK1CA12CA9F11CA1
SCHEMBL6030031 0.64
SCHEMBL2947571 0.63 CA12 (0.62) MAPK1CA12CA9F11CA1
SCHEMBL4288324 0.63 CA12 (0.52) MAPK1CA12CA9F11CA1
SCHEMBL14742903 0.63 CA12 (0.65) MAPK1CA12CA9F11CA1
SCHEMBL1081106 0.63 CA12 (0.52) MAPK1CA12CA9F11CA1
SCHEMBL18073940 0.60 CYP2A6 (0.51) MAPK1CA12CA9F11CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001016139-A9 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARM INC (US) 2002-09-19 WO disclosed
EP-1212330-A1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2002-06-12 EP disclosed
WO-2001016139-A1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2001-03-08 WO disclosed